We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Covering thalidomide, lenalidomide, and pomalidomide: temporary guidance for pregnancy prevention arrangements for patients taking them during COVID-19
This South African study assesses the impact of different incentives on the productivity and quality of outputs of 132 participants
This report provides an updated harms assessment to the ACMD's previous reports on synthetic cannabinoid receptor agonists.
Information on carrying medicine containing controlled drugs for individual travellers entering or leaving the UK.
Licence and registration application information for companies that deal in precursor chemicals.
FCDO travel advice for Japan. Includes safety and security, insurance, entry requirements and legal differences.
Recommendations from the ACMD to reduce barriers to research for schedule 1 controlled drugs.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).